123 related articles for article (PubMed ID: 20204273)
21. Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer.
Witton CJ; Reeves JR; Going JJ; Cooke TG; Bartlett JM
J Pathol; 2003 Jul; 200(3):290-7. PubMed ID: 12845624
[TBL] [Abstract][Full Text] [Related]
22. Nuclear HER3 is associated with favorable overall survival in uveal melanoma.
Trocmé E; Mougiakakos D; Johansson CC; All-Eriksson C; Economou MA; Larsson O; Seregard S; Kiessling R; Lin Y
Int J Cancer; 2012 Mar; 130(5):1120-7. PubMed ID: 21484789
[TBL] [Abstract][Full Text] [Related]
23. Relationship between the expression of versican and EGFR, HER-2, HER-3 and CD44 in matrix-producing tumours in the canine mammary gland.
Damasceno KA; Ferreira E; Estrela-Lima A; Bosco Y; Silva LP; Barros AL; Bertagnolli AC; Cassali GD
Histol Histopathol; 2016 Jun; 31(6):675-88. PubMed ID: 26666308
[TBL] [Abstract][Full Text] [Related]
24. A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.
Pelosi G; Scarpa A; Veronesi G; Spaggiari L; Del Curto B; Moore PS; Maisonneuve P; Sonzogni A; Masullo M; Viale G
Virchows Arch; 2005 Dec; 447(6):969-77. PubMed ID: 16158183
[TBL] [Abstract][Full Text] [Related]
25. The involvement of EGFR, HER2 and HER3 in the basal cell carcinomas aggressiveness.
Florescu DE; Stepan AE; Mărgăritescu C; Ciurea RN; Stepan MD; Simionescu CE
Rom J Morphol Embryol; 2018; 59(2):479-484. PubMed ID: 30173251
[TBL] [Abstract][Full Text] [Related]
26. Prognostic influence of the co-expression of epidermal growth factor receptor and c-erbB-2 protein in human lung adenocarcinoma.
Tateishi M; Ishida T; Kohdono S; Hamatake M; Fukuyama Y; Sugimachi K
Surg Oncol; 1994 Apr; 3(2):109-13. PubMed ID: 7952390
[TBL] [Abstract][Full Text] [Related]
27. Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma.
Hughes DP; Thomas DG; Giordano TJ; Baker LH; McDonagh KT
Cancer Res; 2004 Mar; 64(6):2047-53. PubMed ID: 15026342
[TBL] [Abstract][Full Text] [Related]
28. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
Lipponen P; Eskelinen M
Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
[TBL] [Abstract][Full Text] [Related]
29. Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings.
Molaei M; Pejhan S; Nayer BN; Moradi A; Ghiasi S; Zali MR
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):289-93. PubMed ID: 19279475
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer.
García I; del Casar JM; Corte MD; Allende MT; García-Muñiz JL; Vizoso F
Int J Biol Markers; 2003; 18(3):200-6. PubMed ID: 14535591
[TBL] [Abstract][Full Text] [Related]
31. The type I growth factor receptors in human breast cancer.
Rajkumar T; Gullick WJ
Breast Cancer Res Treat; 1994 Jan; 29(1):3-9. PubMed ID: 7912566
[TBL] [Abstract][Full Text] [Related]
32. EGFR activity in HER-2 over-expressing metastatic breast cancer: evidence for simultaneous phosphorylation of Her-2/neu and EGFR.
Gschwantler-Kaulich D; Hudelist G; Koestler WJ; Czerwenka K; Mueller R; Helmy S; Ruecklinger E; Kubista E; Singer CF
Oncol Rep; 2005 Aug; 14(2):305-11. PubMed ID: 16012707
[TBL] [Abstract][Full Text] [Related]
33. Expression of HER/erbB family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cells.
Ricci C; Landuzzi L; Rossi I; De Giovanni C; Nicoletti G; Astolfi A; Pupa S; Menard S; Scotlandi K; Nanni P; Lollini PL
Int J Cancer; 2000 Jul; 87(1):29-36. PubMed ID: 10861449
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer.
Ferrandina G; Ranelletti FO; Lauriola L; Fanfani F; Legge F; Mottolese M; Nicotra MR; Natali PG; Zakut VH; Scambia G
Gynecol Oncol; 2002 May; 85(2):305-10. PubMed ID: 11972392
[TBL] [Abstract][Full Text] [Related]
35. Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients.
Memon AA; Sorensen BS; Melgard P; Fokdal L; Thykjaer T; Nexo E
Br J Cancer; 2004 Dec; 91(12):2034-41. PubMed ID: 15583696
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of c-erbB-2 and epidermal growth factor receptor in stage A1 (T1a) prostatic adenocarcinoma.
Fox SB; Persad RA; Coleman N; Day CA; Silcocks PB; Collins CC
Br J Urol; 1994 Aug; 74(2):214-20. PubMed ID: 7921940
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer.
Zhang Y; Banerjee S; Wang Z; Xu H; Zhang L; Mohammad R; Aboukameel A; Adsay NV; Che M; Abbruzzese JL; Majumdar AP; Sarkar FH
Cancer Res; 2006 Jan; 66(2):1025-32. PubMed ID: 16424038
[TBL] [Abstract][Full Text] [Related]
38. [Expressions of Her-2, EGFR, PS-2 and ER in breast cancer and their clinical implications].
Xu L; Bai ZH; Xu RC; Yan H; Wang FJ; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):231-3. PubMed ID: 16503540
[TBL] [Abstract][Full Text] [Related]
39. Expression of EGFR, HER-2/neu and KIT in germ cell tumours.
Durán I; García-Velasco A; Ballestín C; García E; Martínez-Tello F; Pond GR; García-Carbonero R; Cortés-Funés H; Paz-Ares L
Clin Transl Oncol; 2010 Jun; 12(6):443-9. PubMed ID: 20534400
[TBL] [Abstract][Full Text] [Related]
40. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
